Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt No Debt
AHPI's Cash to Debt is ranked higher than
98% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 2.59 vs. AHPI: No Debt )
Ranked among companies with meaningful Cash to Debt only.
AHPI' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 10000.00 Max: No Debt
Current: No Debt
Equity to Asset 0.80
AHPI's Equity to Asset is ranked higher than
76% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. AHPI: 0.80 )
Ranked among companies with meaningful Equity to Asset only.
AHPI' s Equity to Asset Range Over the Past 10 Years
Min: 0.47  Med: 0.81 Max: 0.87
Current: 0.8
0.47
0.87
Interest Coverage No Debt
AHPI's Interest Coverage is ranked higher than
98% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 53.44 vs. AHPI: No Debt )
Ranked among companies with meaningful Interest Coverage only.
AHPI' s Interest Coverage Range Over the Past 10 Years
Min: 63.65  Med: 10000.00 Max: 9999.99
Current: No Debt
63.65
9999.99
F-Score: 5
Z-Score: 1.81
M-Score: -2.92
WACC vs ROIC
9.04%
-11.59%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -6.54
AHPI's Operating margin (%) is ranked lower than
58% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 1.90 vs. AHPI: -6.54 )
Ranked among companies with meaningful Operating margin (%) only.
AHPI' s Operating margin (%) Range Over the Past 10 Years
Min: -33.07  Med: -1.60 Max: 4.28
Current: -6.54
-33.07
4.28
Net-margin (%) -6.48
AHPI's Net-margin (%) is ranked lower than
59% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.86 vs. AHPI: -6.48 )
Ranked among companies with meaningful Net-margin (%) only.
AHPI' s Net-margin (%) Range Over the Past 10 Years
Min: -32.19  Med: -1.14 Max: 2.91
Current: -6.48
-32.19
2.91
ROE (%) -10.98
AHPI's ROE (%) is ranked lower than
61% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 1.52 vs. AHPI: -10.98 )
Ranked among companies with meaningful ROE (%) only.
AHPI' s ROE (%) Range Over the Past 10 Years
Min: -47.88  Med: -1.91 Max: 4.15
Current: -10.98
-47.88
4.15
ROA (%) -9.04
AHPI's ROA (%) is ranked lower than
59% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: -0.71 vs. AHPI: -9.04 )
Ranked among companies with meaningful ROA (%) only.
AHPI' s ROA (%) Range Over the Past 10 Years
Min: -39.21  Med: -1.58 Max: 3.46
Current: -9.04
-39.21
3.46
ROC (Joel Greenblatt) (%) -14.05
AHPI's ROC (Joel Greenblatt) (%) is ranked lower than
57% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 3.61 vs. AHPI: -14.05 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
AHPI' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -70.94  Med: -3.50 Max: 10.19
Current: -14.05
-70.94
10.19
Revenue Growth (3Y)(%) -6.20
AHPI's Revenue Growth (3Y)(%) is ranked lower than
73% of the 229 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. AHPI: -6.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
AHPI' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -17.8  Med: -6.00 Max: 0
Current: -6.2
-17.8
0
EPS Growth (3Y)(%) 62.00
AHPI's EPS Growth (3Y)(%) is ranked higher than
90% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. AHPI: 62.00 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
AHPI' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -71  Med: -16.25 Max: 100.9
Current: 62
-71
100.9
» AHPI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

AHPI Guru Trades in Q1 2015

Jim Simons 26,900 sh (+12.08%)
Chuck Royce 86,997 sh (-30.40%)
» More
Q2 2015

AHPI Guru Trades in Q2 2015

Jim Simons 30,700 sh (+14.13%)
Chuck Royce 45,172 sh (-48.08%)
» More
Q3 2015

AHPI Guru Trades in Q3 2015

Jim Simons 33,600 sh (+9.45%)
Chuck Royce 21,471 sh (-52.47%)
» More
Q4 2015

AHPI Guru Trades in Q4 2015

Jim Simons 38,100 sh (+13.39%)
Chuck Royce Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with AHPI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.28
AHPI's P/B is ranked higher than
98% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 2.93 vs. AHPI: 0.28 )
Ranked among companies with meaningful P/B only.
AHPI' s P/B Range Over the Past 10 Years
Min: 0.27  Med: 1.02 Max: 2.09
Current: 0.28
0.27
2.09
P/S 0.15
AHPI's P/S is ranked higher than
99% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 3.18 vs. AHPI: 0.15 )
Ranked among companies with meaningful P/S only.
AHPI' s P/S Range Over the Past 10 Years
Min: 0.15  Med: 0.64 Max: 1.11
Current: 0.15
0.15
1.11
POCF 21.61
AHPI's POCF is ranked lower than
51% of the 131 Companies
in the Global Medical Devices industry.

( Industry Median: 21.24 vs. AHPI: 21.61 )
Ranked among companies with meaningful POCF only.
AHPI' s POCF Range Over the Past 10 Years
Min: 7.36  Med: 19.68 Max: 976.67
Current: 21.61
7.36
976.67
EV-to-EBIT -1.59
AHPI's EV-to-EBIT is ranked lower than
99.99% of the 160 Companies
in the Global Medical Devices industry.

( Industry Median: 21.14 vs. AHPI: -1.59 )
Ranked among companies with meaningful EV-to-EBIT only.
AHPI' s EV-to-EBIT Range Over the Past 10 Years
Min: -19998.7  Med: -1.60 Max: 184.2
Current: -1.59
-19998.7
184.2
EV-to-EBITDA -3.49
AHPI's EV-to-EBITDA is ranked lower than
99.99% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 17.32 vs. AHPI: -3.49 )
Ranked among companies with meaningful EV-to-EBITDA only.
AHPI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -35.4  Med: 11.70 Max: 93.2
Current: -3.49
-35.4
93.2
Current Ratio 3.07
AHPI's Current Ratio is ranked higher than
55% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.86 vs. AHPI: 3.07 )
Ranked among companies with meaningful Current Ratio only.
AHPI' s Current Ratio Range Over the Past 10 Years
Min: 1.57  Med: 3.46 Max: 5.06
Current: 3.07
1.57
5.06
Quick Ratio 1.19
AHPI's Quick Ratio is ranked lower than
73% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. AHPI: 1.19 )
Ranked among companies with meaningful Quick Ratio only.
AHPI' s Quick Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.45 Max: 2.71
Current: 1.19
0.71
2.71
Days Inventory 120.78
AHPI's Days Inventory is ranked higher than
55% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 136.13 vs. AHPI: 120.78 )
Ranked among companies with meaningful Days Inventory only.
AHPI' s Days Inventory Range Over the Past 10 Years
Min: 93.87  Med: 112.00 Max: 124.39
Current: 120.78
93.87
124.39
Days Sales Outstanding 38.90
AHPI's Days Sales Outstanding is ranked higher than
88% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 70.17 vs. AHPI: 38.90 )
Ranked among companies with meaningful Days Sales Outstanding only.
AHPI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 36.8  Med: 41.83 Max: 47.12
Current: 38.9
36.8
47.12
Days Payable 25.62
AHPI's Days Payable is ranked lower than
84% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 62.81 vs. AHPI: 25.62 )
Ranked among companies with meaningful Days Payable only.
AHPI' s Days Payable Range Over the Past 10 Years
Min: 13.42  Med: 18.60 Max: 27.05
Current: 25.62
13.42
27.05

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 0.54
AHPI's Price/Net Current Asset Value is ranked higher than
99% of the 215 Companies
in the Global Medical Devices industry.

( Industry Median: 6.20 vs. AHPI: 0.54 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
AHPI' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 0.88  Med: 2.72 Max: 10.62
Current: 0.54
0.88
10.62
Price/Tangible Book 0.28
AHPI's Price/Tangible Book is ranked higher than
98% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 3.89 vs. AHPI: 0.28 )
Ranked among companies with meaningful Price/Tangible Book only.
AHPI' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.35  Med: 1.28 Max: 7.77
Current: 0.28
0.35
7.77
Price/Projected FCF 0.39
AHPI's Price/Projected FCF is ranked higher than
95% of the 118 Companies
in the Global Medical Devices industry.

( Industry Median: 2.08 vs. AHPI: 0.39 )
Ranked among companies with meaningful Price/Projected FCF only.
AHPI' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.38  Med: 0.89 Max: 1.89
Current: 0.39
0.38
1.89
Price/Median PS Value 0.24
AHPI's Price/Median PS Value is ranked higher than
95% of the 246 Companies
in the Global Medical Devices industry.

( Industry Median: 1.04 vs. AHPI: 0.24 )
Ranked among companies with meaningful Price/Median PS Value only.
AHPI' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.25  Med: 0.83 Max: 1.66
Current: 0.24
0.25
1.66
Earnings Yield (Greenblatt) (%) -62.90
AHPI's Earnings Yield (Greenblatt) (%) is ranked lower than
93% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 0.50 vs. AHPI: -62.90 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
AHPI' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.5  Med: 3.50 Max: 7.4
Current: -62.9
0.5
7.4
Forward Rate of Return (Yacktman) (%) 15.66
AHPI's Forward Rate of Return (Yacktman) (%) is ranked higher than
74% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 6.44 vs. AHPI: 15.66 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
AHPI' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -11.3  Med: 2.40 Max: 7.7
Current: 15.66
-11.3
7.7

More Statistics

Revenue(Mil) $35
EPS $ -0.29
Beta0.96
Short Percentage of Float1.07%
52-Week Range $0.63 - 1.75
Shares Outstanding(Mil)8.03

Business Description

Industry: Medical Devices » Medical Devices
Compare:ASX:ALT, TSE:5212, ASX:RSH, OTCPK:ACAR, XSAT:ZENI, NAS:ETRM » details
Allied Healthcare Products, Inc. was incorporated in Delaware. It manufactures a variety of respiratory products used in the health care industry in a wide range of hospital and alternate site settings, including sub-acute care facilities, home health care and emergency medical care. The Company's product lines include respiratory care products, medical gas equipment and emergency medical products. Respiratory care products are used in the treatment of acute and chronic respiratory disorders such as asthma, emphysema, bronchitis and pneumonia. Respiratory care products are used in both hospitals and alternate care settings. These products include large volume air compressors, calibration equipment, humidifiers, croup tents, equipment dryers and a complete line of respiratory disposable products such as oxygen tubing, facemasks, cannulas and ventilator circuits. Its broad line of home respiratory care products include aluminum oxygen cylinders, oxygen regulators, pneumatic nebulizers, portable suction equipment and the full line of respiratory disposable products. The market for medical gas equipment consists of hospitals, alternate care settings and surgery centers. The medical gas equipment group is broken down into three separate categories: construction products, regulation devices and suction equipment, and disposable cylinders. Emergency medical products are used in the treatment of trauma-induced injuries. The Company's emergency medical products provide patient resuscitation or ventilation during cardiopulmonary resuscitation or respiratory distress as well as immobilization and treatment for burns. The Company's respiratory/resuscitation products include demand resuscitation valves, portable resuscitation systems, bag masks and related products, emergency transport ventilators, precision oxygen regulators, minilators, multilators and humidifiers. Its trauma and patient handling products include spine immobilization products, pneumatic anti-shock garments and trauma burn kits. Spine immobilization products include a backboard that is designed for safe immobilization of injury victims and provides a durable and cost effective means of emergency patient transportation and extrication. The Company's products are marketed under well-recognized and respected brand names to hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, emergency medical products dealers and others. It sells its products primarily to respiratory care/anesthesia product distributors, hospital construction contractors, emergency medical equipment dealers and directly to hospitals. Most of these competitors have greater financial and other resources. The Company is subject to federal, state and local environmental laws and regulations that impose limitations on the discharge of pollutants into the environment and establish standards for the treatment, storage and disposal of toxic and hazardous wastes.
» More Articles for AHPI

Headlines

Articles On GuruFocus.com
Weekly 3-Year Low Highlight: TEU, KIPO, GNI, PTNT, AHPI Feb 16 2014 
Allied Healthcare Products Inc. Reports Operating Results (10-Q) Feb 08 2011 
Allied Healthcare Products Inc. Reports Operating Results (10-Q) Nov 05 2010 
Allied Healthcare Products Inc. Reports Operating Results (10-Q) May 07 2010 
Allied Healthcare Products Inc. Reports Operating Results (10-Q) Feb 08 2010 
Allied Healthcare Products Inc. Reports Operating Results (10-Q) Nov 06 2009 
Allied Healthcare Products Inc. Reports Operating Results (10-Q) May 12 2009 
Allied Healthcare Products Inc. Reports Operating Results (10-Q) Feb 10 2009 

More From Other Websites
ALLIED HEALTHCARE PRODUCTS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Apr 06 2016
New York Appellate Court Rules Against Allied Healthcare Products in Stuyvesant Falls Power Covenant... Apr 04 2016
Allied Healthcare gets another Nasdaq warning Mar 01 2016
ALLIED HEALTHCARE PRODUCTS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Feb 29 2016
OxySure (OXYS) Ramps Up Production as Growth Continues Feb 25 2016
ALLIED HEALTHCARE PRODUCTS INC Financials Feb 19 2016
ALLIED HEALTHCARE PRODUCTS INC Files SEC form 10-Q, Quarterly Report Feb 16 2016
Allied Healthcare Products, Inc. Earnings Q1, 2016 Nov 30 2015
ALLIED HEALTHCARE PRODUCTS INC Files SEC form 8-K, Submission of Matters to a Vote of Security... Nov 16 2015
ALLIED HEALTHCARE PRODUCTS INC Files SEC form 10-Q, Quarterly Report Nov 13 2015
Allied Healthcare Products gets Nadaq warning Oct 01 2015
ALLIED HEALTHCARE PRODUCTS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Sep 30 2015
Ebola Fears Driving Ebola Stock Winners Oct 13 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK